| Characteristic | N | N of events | Cumulative DFS at 12 ms (%) | Cumulative DFS at 36 ms (%) | Cumulative DFS at 60 ms (%) | Median DFS estimate (ms) | P-value |
| Whole group | 27 | 12 | 58.7 | 40.7 | 40.7 | 17.83 | NA |
| Gender: |
|
|
|
|
|
|
|
| Male Female | 18 9 | 7 5 | 63.5 50.8 | 41.7 38.1 | NR 38.1 | 28.98 17.83 | 0.569
|
| Age Categories: |
|
|
|
|
|
|
|
| ≤50 | 9 | 3 | 85.7 | 51.4 | 51.4 | NR | 0.327 |
| >50 | 18 | 9 | 46.9 | 31.3 | NR | 11.18 |
|
| ≤60 | 17 | 8 | 60.6 | 32.5 | 32.5 | 17.83 |
|
| >60 | 10 | 4 | 55.6 | 55.6 | NR | NR | 0.659 |
| Residence: |
|
|
|
|
|
|
|
| Rural Urban | 19 8 | 7 5 | 52.3 71.4 | 52.3 NR | 52.3 NR | NR 17.83 | 0.727
|
| Curative Sx: |
|
|
|
|
|
|
|
| RC + PC APE | 22 5 | 10 2 | 58.6 60.0 | 34.2 60.0 | NR 60.0 | 17.83 NA | 0.509
|
| Main complaint: |
|
|
|
|
|
|
|
| Hematuria Others | 25 2 | 11 1 | 61.4 NR | 42.6 NR | 42.6 NR | 28.98 2.37 | *
|
| Tumour Growth: |
|
|
|
|
|
|
|
| Fungating Ulcerative |
|
|
|
|
|
|
|
| Tumour Size(cm) |
|
|
|
|
|
|
|
| ≤5 >5 | 21 6 | 12 0 | 50.2 100 | 29.3 NR | 29.3 NR | 18.0 NR | 0.054
|
| Tumour Location: |
|
|
|
|
|
|
|
| Posterior wall Others | 16 11 | 7 5 | 60.6 56.3 | 41.5 45.0 | 41.5 NR | 28.98 12.86 | 0.818
|
| Clinical stage# |
|
|
|
|
|
|
|
| II III & IV | 24 3 | 10 2 | 63.1 33.3 | 41.3 NR | NR NR | 28.98 10.13 | *
|
| pT: |
|
|
|
|
|
|
|
| pT2 pT3 & 4 | 9 18 | 2 10 | 85.7 46.9 | 57.1 33.5 | 57.1 NR | NR 11.18 | 0.126
|
| pN: |
|
|
|
|
|
|
|
| Negative Positive | 22 5 | 8 4 | 66.2 25.0 | 50.2 NR | 50.2 NR | NR 2.37 | 0.011
|
| Hydronephrosis: |
|
|
|
|
|
|
|
| Present Absent | 13 14 | 8 4 | 36.4 81.8 | 27.3 53.7 | NR 53.7 | 10.13 NR | 0.047
|
| Pathology: |
|
|
|
|
|
|
|
| AC (NOS) MAC & SRAC | 21 6 | 9 3 | 64.6 40.0 | 41.3 40.0 | NR 40.0 | 28.98 10.13 | 0.720
|
| Tumour grade: |
|
|
|
|
|
|
|
| II III | 21 6 | 7 5 | 76.5 NR | 53.1 NR | 53.1 NR | NR 7.04 | 0.001
|
| Bilharziasis: |
|
|
|
|
|
|
|
| Yes No | 13 14 | 6 6 | 36.0 75.0 | 36 43.8 | 36 NR | 10.13 28.98 | 0.272
|